CA
NZ
UK
AU
IND
US
Arcturus Therapeutics (NASDAQ:ARCT) has enlisted Thermo Fisher Scientific to help manufacture and eventually commercialize ARCT-032, its inhaled mRNA candidate for cystic fibrosis, ahead of a planned Phase 3 program. The San Diego company, whose approved KOSTAIVE COVID-19 vaccine is commercialized through partners, reported shrinking …
Arq, Inc. (NASDAQ:ARQ) built a granular activated-carbon line at its Red River Plant to chase PFAS-driven clean-water demand, but design flaws capped output short of nameplate capacity. The company paused GAC production in March 2026, idled its Corbin facility, and expects no GAC output …
Akari Therapeutics, Plc (NASDAQ:AKTX) has entered a preclinical research collaboration with Whitehawk Therapeutics to test whether its RNA-splicing payload, PH1, can be combined with Whitehawk's topoisomerase I inhibitor ADC platform. Announced July 21, 2026, the deal arrives as Akari pushes its lead candidate, AKTX-101, …
PACCAR Inc, a major manufacturer of medium and heavy-duty commercial vehicles, announced its second quarter 2026 financial results on July 28, 2026. The company disclosed the quarterly performance metrics and confirmed that management would hold a conference call with securities analysts on the same …
CTS Corporation disclosed its financial results for the second quarter ended June 30, 2026, on July 28, 2026. The company issued a press release detailing operational performance and hosted a live webcast to discuss the quarterly findings with investors. The disclosure updates shareholders on …
CTS Corporation disclosed on July 28, 2026, that an investor presentation may be presented to investors, analysts, and other parties throughout the remainder of fiscal year 2026. The disclosure was made via a current report that includes the presentation as an exhibit. The company …
Dynex Capital, Inc., a real estate investment trust specializing in mortgage-related investments, filed a prospectus supplement on July 28, 2026, authorizing the sale of approximately 99.3 million shares of common stock under an expanded continuous distribution agreement. The company has engaged ten major financial …
Dynex Capital, Inc., a Virginia-based mortgage real estate investment trust, has executed Amendment No. 10 to its distribution agreement, increasing the total share authorization for at-the-market offerings to 301.3 million shares. The amendment, signed on July 28, 2026, maintains a syndicate of ten major …
Turn Therapeutics Inc., a Delaware-incorporated biopharmaceutical company based in Westlake Village, California, disclosed the release of an updated investor presentation on July 28, 2026. The presentation was furnished to the Securities and Exchange Commission as part of a current report filing. The update provides …
Actelis Networks, Inc. (OTC:ASNS) and Israel-based Exaware Routing Ltd. have signed a memorandum of understanding to jointly pursue critical-infrastructure networking customers, a scaled-back deal that succeeds the outright acquisition the two companies proposed in March. The move comes as Actelis rebuilds investor confidence after …
Please wait processing your request...